Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks.


Sometimes it pays to team up. That's what Novo Nordisk (NYSE: NVO) and Ginkgo Bioworks (NYSE: DNA) decided to do April 10 when they launched a new manufacturing collaboration that could benefit both companies. Details about the financial terms of their team-up are scarce, but there are at least a few reasons why shareholders should be optimistic.

Here's what's going on, and some points to consider if you're pondering an investment in either business right now.

The new strategic partnership between Novo Nordisk and Ginkgo will cover five years, and it builds upon an earlier and much smaller collaboration program.

Continue reading


Source Fool.com

Like: 0
NVO
Share

Comments